[Impact of Bestim on the immunological status and clinical course of ulcer].
Observational study · 2004
- What was studied
- Patients receiving combined antiulcer treatment; sample size absent from abstract
- Main finding
- The report describes immune-marker changes, symptom regression and ulcer scarring with adjunctive Bestim.
Study data at a glance
- Participants or experimental model
- Patients receiving combined antiulcer treatment; sample size absent from abstract
- Reported results
- The report describes immune-marker changes, symptom regression and ulcer scarring with adjunctive Bestim.
Study limitations and source details
Study limitations
- Sample size, comparator details and quantitative effects require the full report; this is not reliable evidence of standalone efficacy.
- Full methods, reporting completeness and independent replication remain to be appraised.
Source details
Original journal report
Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.
Abstract reviewed
Sources checked
Citation
Tkacheva AG, Kalev OF, Dolgushina AI, Antipina TV. [Impact of Bestim on the immunological status and clinical course of ulcer]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology · PMID 16259438